Synovics Pharmaceuticals Valuation
| SYVC Stock | USD 0.0001 0.00 0.00% |
Synovics Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Synovics Pharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 29.83 M, operating margin of (1.18) %, and Return On Equity of -3.14 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Synovics Pharmaceuticals' valuation include:
Overvalued
Today
Please note that Synovics Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Synovics Pharmaceuticals is based on 3 months time horizon. Increasing Synovics Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Synovics Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Synovics Stock. However, Synovics Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The real value of Synovics Stock, also known as its intrinsic value, is the underlying worth of Synovics Pharmaceuticals Company, which is reflected in its stock price. It is based on Synovics Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Synovics Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Synovics Pharmaceuticals helps investors to forecast how Synovics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Synovics Pharmaceuticals more accurately as focusing exclusively on Synovics Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Synovics Pharmaceuticals' intrinsic value based on its ongoing forecasts of Synovics Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Synovics Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Synovics Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Synovics Pharmaceuticals Cash |
|
About Synovics Pharmaceuticals Valuation
The stock valuation mechanism determines Synovics Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Synovics Pharmaceuticals. We calculate exposure to Synovics Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Synovics Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 10.3 M | 10.8 M | |
| Pretax Profit Margin | (0.14) | (0.15) | |
| Operating Profit Margin | (0.09) | (0.09) | |
| Net Loss | (0.18) | (0.19) | |
| Gross Profit Margin | 0.31 | 0.33 |
Synovics Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Synovics Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Synovics we look at many different elements of the entity such as Synovics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Synovics Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Synovics Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Synovics Pharmaceuticals' worth.Complementary Tools for Synovics Stock analysis
When running Synovics Pharmaceuticals' price analysis, check to measure Synovics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synovics Pharmaceuticals is operating at the current time. Most of Synovics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Synovics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synovics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Synovics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |